Skip to main content
Clinical Trials/NCT06286969
NCT06286969
Not yet recruiting
Not Applicable

Clinical Study on the Treatment of Lumbar Muscle Strain by Intensive Multi-acupuncture Method Based on the Principle of "Tendons Disease Pain-point Needling".

Xu Xinnan0 sites108 target enrollmentMarch 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lumbar Muscle Strain
Sponsor
Xu Xinnan
Enrollment
108
Primary Endpoint
clinical efficacy evaluation criteria
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

Acupuncture is widely used as a routine treatment for lumbar muscle strain. The aim of this randomized controlled trial is to evaluate the effectiveness of the intensive multi-acupuncture method. This trial will include 108 patients with lumbar muscle strain injury from two outpatient clinics. All participants will be randomized in a 1:1 ratio to the intensive multi-acupuncture method group and the normal needling group. Outcomes will be assessed before the intervention, after one treatment, after five treatments, and at follow-up 2 weeks after the end of treatment. The primary outcome indicator will be the clinical efficacy evaluation criteria, and the secondary outcome indicators will be the pain visual analog scale (VAS) score, the Japanese Orthopaedic Association Assessment Treatment Score (JOA) score, the lumbar joint mobility measurement scale, and the Modified Ashworth Grading Scale. This study will provide evidence as to whether the intensive multi-acupuncture method is safe and effective.

Registry
clinicaltrials.gov
Start Date
March 1, 2024
End Date
March 1, 2025
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Xu Xinnan
Responsible Party
Sponsor Investigator
Principal Investigator

Xu Xinnan

medical student

The Third Affiliated hospital of Zhejiang Chinese Medical University

Eligibility Criteria

Inclusion Criteria

  • 1.Meet the above Chinese and Western medicine diagnostic criteria; 2.18 years old ≤ age ≤ 70 years old, gender is not limited; 3.The duration of the disease is more than 3 months, no other treatment has been received in the last month, and the VAS score is ≥4 at the time of participating in the treatment; 4.Voluntarily cooperate with the examination and treatment, and sign the Informed Consent Form.

Exclusion Criteria

  • Those with severe cardiac, hepatic and renal insufficiency and those with bleeding tendency;
  • Previous history of lumbar spine surgery, spinal cauda equina tumor, lumbar spondylolisthesis, lumbar spinal stenosis, scoliosis deformity, tumors and other diseases caused by low back pain;
  • Women who are in the period of pregnancy or breastfeeding should not perform acupuncture treatment;
  • Those who have needle-sickness, blood-sickness and so on;
  • Those who have cognitive impairment and cannot complete the relevant scale assessment independently or under the guidance of the investigator.

Outcomes

Primary Outcomes

clinical efficacy evaluation criteria

Time Frame: Outcomes will be assessed after one treatment, after five treatments, and at follow-up 2 weeks after the end of treatment.

It was evaluated according to the efficacy standard of lumbar muscle strain injury in the Guidelines for Clinical Research of New Chinese Medicines, and the JOA index was used as the benchmark: Efficacy index (N) = \[(pre-treatment score - post-treatment score) ÷ pre-treatment score\] × 100% * cure: the patient does not feel obvious back pain and other discomforts, N ≥ 90% * Effective: Effective: low back pain is significantly relieved, 60% ≤ N \< 90% ③ Effective: lower back pain is relieved, 30%≤N\<60%. ④ Ineffective: the patient's low back pain is not relieved, N\<30%. Total effective rate (%) = \[(number of cured + number of effective + number of effective) ÷ number of cases in each group\] × 100%.

Secondary Outcomes

  • Lumbar Joint Mobility Measurement Scale(Outcomes will be assessed before the intervention, after one treatment, after five treatments, and at follow-up 2 weeks after the end of treatment.)
  • Improvement of the Ashworth Rating Scale(Outcomes will be assessed before the intervention, after one treatment, after five treatments, and at follow-up 2 weeks after the end of treatment.)
  • Pain visual analog scale (VAS) score(Outcomes will be assessed before the intervention, after one treatment, after five treatments, and at follow-up 2 weeks after the end of treatment.)
  • Japanese Orthopaedic Association Scores(Outcomes will be assessed before the intervention, after one treatment, after five treatments, and at follow-up 2 weeks after the end of treatment.)

Similar Trials